StocksFin Logo
IRWD logo
$IRWD

Ironwood Pharmaceuticals, Inc.

IRWD country of incorporation
|
https://www.ironwoodpharma.com
|
Mr. Mark Mallon
|
219 employees
NASDAQ | Healthcare | Drug Manufacturers—Specialty & Generic
IRWD reported its Q322 earnings on November 3, 2022 (98 weeks ago).
$108.64M 4.7% vs. Q321 Revenues Q322
0% -100% vs. Q321 Gross Profit Margin
46.32% -14% vs. Q321 Net Profit Margin
69.03M -7.9% vs. Q321 Free Cash Flow Q322
$0.33 -2.9% vs. Q321 EPS Q322
Company Card Q322
As reported on November 3, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q322
As reported on November 3, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
108.64M
+11.7%
0
50.32M
+35.7%
$0.33
Q22022
97.23M
-0.3%
0
37.08M
-4.4%
$0.24
Q12022
97.53M
0
38.8M
$0.25
FY2021
413.75M
 0
528.45M
$3.26
Q42021
117.13M
+12.9%
0
41.37M
-25.9%
$0.25
Q32021
103.75M
-0.3%
0
55.85M
-85.7%
$0.34
Q22021
104.03M
+17.1%
0
391.3M
+880.1%
$2.42
Q12021
88.85M
0
39.93M
$0.25
FY2020
389.52M
 3.14M
106.18M
$0.67
FY2019
428.41M
 23.88M
21.51M
$0.14
FY2018
346.64M
 32.75M
-282.37M
$-1.85
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
1.04B
 449.28M
574.19M
415.99M
591.06M
Q22022
975.69M
 442.81M
504.37M
416.08M
532.88M
Q12022
1.08B
 565.6M
593.37M
536.76M
517.78M
FY2021
1.13B
 521.02M
620.13M
595.79M
605.91M
FY2020
559.24M
 496.6M
362.56M
436.51M
62.64M
FY2019
402.75M
 496M
177.02M
410.29M
-93.25M
FY2018
332.05M
 528.42M
173.17M
461.39M
-196.37M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
69.09M
 -66k
797k
-66k
69.03M
+12.6%
Q22022
61.37M
 -88k
-150.28M
-88k
61.28M
-4.4%
Q12022
64.12M
 -9k
-90.87M
-9k
64.12M
FY2021
261.9M
 -265k
-4.55M
-265k
261.63M
FY2020
168.84M
 -1.84M
18.55M
-1.84M
166.99M
FY2019
10.73M
 -11.14M
-1.19M
-7.19M
3.54M
FY2018
-70.88M
 88.87M
30.07M
-8.62M
-79.5M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees